4CPS-118 Implementation of quality indicators for hospital pharmacy services in a university hospital

<h3>Background and Importance</h3> Quality indicators (QI) for hospital pharmacy services are measurement tools used to evaluate and improve the performance of hospital pharmacists (HPs). Unlike traditional workload measurements, these QI measure services delivered by HPs in order to optimise the use of medicines and medical devices. <h3>Aim and Objectives</h3> The objectives of this study were to describe the national set of QI for hospital pharmacy services, and report their scores over 2024 in a university hospital. <h3>Material and Methods</h3> In February 2024 we started implementing the national set of QI for hospital pharmacy services in a university hospital. Indicators were self-reported by HPs (N=41) and scores were expressed as: (i) number of reported adverse reactions to medicines and medical devices, (ii) number of reported quality deviations of medicines and medical devices, (iii) number of internal education programmes for healthcare professionals on medicines and medical devices, (iv) number of information and instructions to healthcare professionals on medicines and medical devices provided by HP, and (v) medication review of intrahospital antimicrobial use in intensive care units (ICU) (number of interventions/total number of patients in ICU * 100). <h3>Results</h3> Number of reported adverse reactions and quality deviations of medicines and medical devices were low throughout 2024 (not more than 5). There was only 1 internal education programme for healthcare professionals (physicians, nurses, HPs) regarding the new website and mobile application for antibiotic reconstitution held every two months. When it comes to clinical pharmacy services, the highest number of information given to healthcare professionals by HPs was recorded in March (176) and April (135) and the lowest in June (6). Furthermore, the number of antimicrobial stewardship interventions in ICU was more than 1000 in all reported months, except June (437.5). The noticeable differences in scores were due to variations in number of HPs reporting their pharmaceutical services (11/41 and less). <h3>Conclusion and Relevance</h3> QI enables better insight into the quality of pharmaceutical services provided by HPs and make them more aware about their own performances. These preliminary data indicate the need for further research on whether modest reporting of pharmaceutical services is due to lack of time or skills and the importance of further encouragement. <h3>References and/or Acknowledgements</h3> <h3>Conflict of Interest</h3> No conflict of interest